IGFBP-3 Sensitizes Prostate Cancer Cells to Interferon-gamma-induced Apoptosis

Overview

Journal Growth Horm IGF Res

Publisher Elsevier

Specialty Endocrinology

Date 2007 Aug 28

PMID 17719815

Citations 4

Authors

Peng Fang

Vivian Hwa

Brian M Little

Ron G Rosenfeld

Affiliations

Soon will be listed here.

Abstract

Objective: Insulin-like growth factor binding protein-3 (IGFBP-3) has been shown to exhibit diverse biological actions, including IGF-independent effects on cell growth and cell death. Here we report that IGFBP-3 sensitizes prostate cancer cells to interferon-gamma (IFN-gamma)-induced apoptosis and inhibition of cell proliferation.

Design: The cell growth or cell death of prostate cells in response to the treatments of IGFBPs and/or IFN-gamma was measured, and the signaling pathways mediating these actions assessed.

Results: Cell proliferation was minimally affected when M12 prostate cancer cells were treated with exogenous IGFBP-3 (1-5 microg/ml), IGFBP-1 (1-5 microg/ml) or IFN-gamma (20 U/ml). However, strong inhibition of cell growth and significant apoptosis were observed when M12 cells were co-treated with IGFBP-3 and IFN-gamma, but not with IGFBP-1 and IFN-gamma. These effects were IGF-independent and appear not to require intracellular localization of IGFBP-3, as similar results were obtained with mutants of IGFBP-3 that either could not bind IGF or has impaired ability to be internalized. Further analyses revealed that IGFBP-3, but not IGFBP-1, could significantly enhance the weak tyrosine phosphorylation of STAT1 induced by IFN-gamma (20 U/ml) alone. The IGFBP-3-promoted apoptosis in the presence of IFN-gamma could also be abrogated by blockade of the mTOR pathway with its pharmacological inhibitors, LY294002 or rapamycin.

Conclusions: These results demonstrated that in a cancer cell line not responsive to exogenous IGFBP-3 alone, IGFBP-3 sensitized the cells to the anti-proliferative, proapoptotic actions of IFN-gamma through an IGF-independent, STAT1- and mTOR-dependent mechanism.

Citing Articles

Efficacy of Naringenin against aging and degeneration of nucleus pulposus cells through IGFBP3 inhibition.

Tang X, Zhong J, Luo H, Zhou F, Wang L, Lin S Sci Rep. 2025; 15(1):6780.

PMID: 40000729 PMC: 11861589. DOI: 10.1038/s41598-025-90909-0.

The Causal Relationships Between Extrinsic Exposures and Risk of Prostate Cancer: A Phenome-Wide Mendelian Randomization Study.

Gu D, Tang M, Wang Y, Cui H, Zhang M, Bai Y Front Oncol. 2022; 12:829248.

PMID: 35237523 PMC: 8882837. DOI: 10.3389/fonc.2022.829248.

Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.

Yin L, Fang Z, Shen N, Qiu Y, Li A, Zhang Y Drug Des Devel Ther. 2017; 11:2841-2850.

PMID: 29033545 PMC: 5628674. DOI: 10.2147/DDDT.S135993.

Evaluation of inflammatory cytokines and oxidative stress markers in prostate cancer patients undergoing curative radiotherapy.

Abdel-Messeih P, Nosseir N, Bakhe O Cent Eur J Immunol. 2017; 42(1):68-72.

PMID: 28680332 PMC: 5470615. DOI: 10.5114/ceji.2017.67319.

Gene Expression Profiling Identifies Interferon Signalling Molecules and IGFBP3 in Human Degenerative Annulus Fibrosus.

Kazezian Z, Gawri R, Haglund L, Ouellet J, Mwale F, Tarrant F Sci Rep. 2015; 5:15662.

PMID: 26489762 PMC: 4614807. DOI: 10.1038/srep15662.

References

Hwa V, Oh Y, Rosenfeld R . The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999; 20(6):761-87. DOI: 10.1210/edrv.20.6.0382. View

Kim H, Ingermann A, Tsubaki J, Twigg S, Walker G, Oh Y . Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res. 2004; 64(6):2229-37. DOI: 10.1158/0008-5472.can-03-1675. View

Fowler C, Perks C, Newcomb P, Savage P, Farndon J, Holly J . Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. Int J Cancer. 2000; 88(3):448-53. View

Liu B, Lee H, Weinzimer S, Powell D, Clifford J, Kurie J . Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 2000; 275(43):33607-13. DOI: 10.1074/jbc.M002547200. View

Fanayan S, Firth S, BUTT A, BAXTER R . Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor. J Biol Chem. 2000; 275(50):39146-51. DOI: 10.1074/jbc.M006964200. View

BUTT A, Firth S, King M, BAXTER R . Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem. 2000; 275(50):39174-81. DOI: 10.1074/jbc.M908888199. View

Spagnoli A, Hwa V, Horton W, Lunstrum G, Roberts Jr C, Chiarelli F . Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. relationship to differentiation stage. J Biol Chem. 2000; 276(8):5533-40. DOI: 10.1074/jbc.M005088200. View

Buckway C, Wilson E, Ahlsen M, Bang P, Oh Y, Rosenfeld R . Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab. 2001; 86(10):4943-50. DOI: 10.1210/jcem.86.10.7936. View

Fanayan S, Firth S, Baxter R . Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J Biol Chem. 2001; 277(9):7255-61. DOI: 10.1074/jbc.M108038200. View

10.

Hong J, Zhang G, Dong F, Rechler M . Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem. 2002; 277(12):10489-97. DOI: 10.1074/jbc.M109604200. View

11.

Ikeda H, Old L, Schreiber R . The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002; 13(2):95-109. DOI: 10.1016/s1359-6101(01)00038-7. View

12.

Spagnoli A, Torello M, Nagalla S, Horton W, Pattee P, Hwa V . Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis. J Biol Chem. 2002; 277(21):18860-7. DOI: 10.1074/jbc.M200218200. View

13.

Devi G, Sprenger C, Plymate S, Rosenfeld R . Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo. Prostate. 2002; 51(2):141-52. DOI: 10.1002/pros.10068. View

14.

Ricort J, Binoux M . Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem. 2002; 277(22):19448-54. DOI: 10.1074/jbc.M200439200. View

15.

Lee H, Chun K, Liu B, Wiehle S, Cristiano R, Hong W . Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res. 2002; 62(12):3530-7. View

16.

Butt A, Fraley K, Firth S, Baxter R . IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology. 2002; 143(7):2693-9. DOI: 10.1210/endo.143.7.8876. View

17.

Mohan S, Baylink D . IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol. 2002; 175(1):19-31. DOI: 10.1677/joe.0.1750019. View

18.

Firth S, Baxter R . Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002; 23(6):824-54. DOI: 10.1210/er.2001-0033. View

19.

Collard T, Guy M, BUTT A, Perks C, Holly J, Paraskeva C . Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis. 2003; 24(3):393-401. DOI: 10.1093/carcin/24.3.393. View

20.

Lee K, Liu B, Ma L, Li H, Bang P, Koeffler H . Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem. 2003; 279(1):469-76. DOI: 10.1074/jbc.M307316200. View